Preparation, characterization and pharmacokinetic study of nelfinavir nanocrystals for oral bioavailability enhancement

Dasari Naga Naresh, Usha Y. Nayak, Prashant Musmade, Srinivas Mutalik, Yogendra Nayak

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The study is aimed at development of nanocrystals of Nelfinavir Mesylate, an anti-HIV drug to overcome the drawback associated with drug such as poor solubility and oral bioavailability. Nanocrystals were attempted by combination technique and ultrasonication method using polyvinyl alcohol (PVA) and poloxamer 407 as stabilizers at various concentrations. The solid-state characteristics of optimized nanocrystals were studied by XRD, FTIR, DSC and SEM analysis. The release behavior of the drug was studied by in vitro dissolution. The in vivo pharmacokinetics was assessed in Wister Albino rats by administering nanocrystals orally. Nelfinavir nanocrystals were obtained with the narrow size distribution and mean particle size was ranged from 216 to 360 nm for the nanocrystals obtained from combination technique. At 0.5% w/w of PVA, particle size was 236 ± 19.23 nm and zeta potential was 18.34 ± 2.0 mV. Freeze dried Poloxamer 407 and PVA nanocrystals showed very good solubility than the freeze dried powder with cryoprotectant and pure drug. However, nanocrystals with PVA (NC PVA) showed high dissolution velocity as compared to nanocrystals with Poloxamer 407 and were supported by high saturation solubility of NC PVA. SEM and other solid-state studies indicated the crystalline nature of developed nanocrystals. Compared to pure drug, NC PVA formulation had decreased Tmax and increased Cmax and AUC0-24. Thus pharmacokinetic study revealed significant increase in oral absorption of the drug with nanocrystals which could be attributed to the increase in dissolution velocity of the Nelfinavir in nanocrystal form.

Original languageEnglish
Pages (from-to)379-387
Number of pages9
JournalCurrent Nanoscience
Volume11
Issue number3
Publication statusPublished - 2015

Fingerprint

Nelfinavir
Pharmacokinetics
Nanoparticles
Nanocrystals
Biological Availability
Polyvinyl Alcohol
Polyvinyl alcohols
Poloxamer
Solubility
Dissolution
Pharmaceutical Preparations
Particle Size
Particle size
Anti-HIV Agents
Saturation (materials composition)
Scanning electron microscopy
Fourier Transform Infrared Spectroscopy
Zeta potential

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Medicine (miscellaneous)
  • Pharmaceutical Science

Cite this

@article{ec1af80beaa8416ca0e032010b4a8f3f,
title = "Preparation, characterization and pharmacokinetic study of nelfinavir nanocrystals for oral bioavailability enhancement",
abstract = "The study is aimed at development of nanocrystals of Nelfinavir Mesylate, an anti-HIV drug to overcome the drawback associated with drug such as poor solubility and oral bioavailability. Nanocrystals were attempted by combination technique and ultrasonication method using polyvinyl alcohol (PVA) and poloxamer 407 as stabilizers at various concentrations. The solid-state characteristics of optimized nanocrystals were studied by XRD, FTIR, DSC and SEM analysis. The release behavior of the drug was studied by in vitro dissolution. The in vivo pharmacokinetics was assessed in Wister Albino rats by administering nanocrystals orally. Nelfinavir nanocrystals were obtained with the narrow size distribution and mean particle size was ranged from 216 to 360 nm for the nanocrystals obtained from combination technique. At 0.5{\%} w/w of PVA, particle size was 236 ± 19.23 nm and zeta potential was 18.34 ± 2.0 mV. Freeze dried Poloxamer 407 and PVA nanocrystals showed very good solubility than the freeze dried powder with cryoprotectant and pure drug. However, nanocrystals with PVA (NC PVA) showed high dissolution velocity as compared to nanocrystals with Poloxamer 407 and were supported by high saturation solubility of NC PVA. SEM and other solid-state studies indicated the crystalline nature of developed nanocrystals. Compared to pure drug, NC PVA formulation had decreased Tmax and increased Cmax and AUC0-24. Thus pharmacokinetic study revealed significant increase in oral absorption of the drug with nanocrystals which could be attributed to the increase in dissolution velocity of the Nelfinavir in nanocrystal form.",
author = "Naresh, {Dasari Naga} and Nayak, {Usha Y.} and Prashant Musmade and Srinivas Mutalik and Yogendra Nayak",
year = "2015",
language = "English",
volume = "11",
pages = "379--387",
journal = "Current Nanoscience",
issn = "1573-4137",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

Preparation, characterization and pharmacokinetic study of nelfinavir nanocrystals for oral bioavailability enhancement. / Naresh, Dasari Naga; Nayak, Usha Y.; Musmade, Prashant; Mutalik, Srinivas; Nayak, Yogendra.

In: Current Nanoscience, Vol. 11, No. 3, 2015, p. 379-387.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Preparation, characterization and pharmacokinetic study of nelfinavir nanocrystals for oral bioavailability enhancement

AU - Naresh, Dasari Naga

AU - Nayak, Usha Y.

AU - Musmade, Prashant

AU - Mutalik, Srinivas

AU - Nayak, Yogendra

PY - 2015

Y1 - 2015

N2 - The study is aimed at development of nanocrystals of Nelfinavir Mesylate, an anti-HIV drug to overcome the drawback associated with drug such as poor solubility and oral bioavailability. Nanocrystals were attempted by combination technique and ultrasonication method using polyvinyl alcohol (PVA) and poloxamer 407 as stabilizers at various concentrations. The solid-state characteristics of optimized nanocrystals were studied by XRD, FTIR, DSC and SEM analysis. The release behavior of the drug was studied by in vitro dissolution. The in vivo pharmacokinetics was assessed in Wister Albino rats by administering nanocrystals orally. Nelfinavir nanocrystals were obtained with the narrow size distribution and mean particle size was ranged from 216 to 360 nm for the nanocrystals obtained from combination technique. At 0.5% w/w of PVA, particle size was 236 ± 19.23 nm and zeta potential was 18.34 ± 2.0 mV. Freeze dried Poloxamer 407 and PVA nanocrystals showed very good solubility than the freeze dried powder with cryoprotectant and pure drug. However, nanocrystals with PVA (NC PVA) showed high dissolution velocity as compared to nanocrystals with Poloxamer 407 and were supported by high saturation solubility of NC PVA. SEM and other solid-state studies indicated the crystalline nature of developed nanocrystals. Compared to pure drug, NC PVA formulation had decreased Tmax and increased Cmax and AUC0-24. Thus pharmacokinetic study revealed significant increase in oral absorption of the drug with nanocrystals which could be attributed to the increase in dissolution velocity of the Nelfinavir in nanocrystal form.

AB - The study is aimed at development of nanocrystals of Nelfinavir Mesylate, an anti-HIV drug to overcome the drawback associated with drug such as poor solubility and oral bioavailability. Nanocrystals were attempted by combination technique and ultrasonication method using polyvinyl alcohol (PVA) and poloxamer 407 as stabilizers at various concentrations. The solid-state characteristics of optimized nanocrystals were studied by XRD, FTIR, DSC and SEM analysis. The release behavior of the drug was studied by in vitro dissolution. The in vivo pharmacokinetics was assessed in Wister Albino rats by administering nanocrystals orally. Nelfinavir nanocrystals were obtained with the narrow size distribution and mean particle size was ranged from 216 to 360 nm for the nanocrystals obtained from combination technique. At 0.5% w/w of PVA, particle size was 236 ± 19.23 nm and zeta potential was 18.34 ± 2.0 mV. Freeze dried Poloxamer 407 and PVA nanocrystals showed very good solubility than the freeze dried powder with cryoprotectant and pure drug. However, nanocrystals with PVA (NC PVA) showed high dissolution velocity as compared to nanocrystals with Poloxamer 407 and were supported by high saturation solubility of NC PVA. SEM and other solid-state studies indicated the crystalline nature of developed nanocrystals. Compared to pure drug, NC PVA formulation had decreased Tmax and increased Cmax and AUC0-24. Thus pharmacokinetic study revealed significant increase in oral absorption of the drug with nanocrystals which could be attributed to the increase in dissolution velocity of the Nelfinavir in nanocrystal form.

UR - http://www.scopus.com/inward/record.url?scp=84930899646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930899646&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 379

EP - 387

JO - Current Nanoscience

JF - Current Nanoscience

SN - 1573-4137

IS - 3

ER -